Alexander Light
@AJWLight
Followers
2K
Following
11K
Media
156
Statuses
3K
NIHR Doctoral Fellow @IP_London @NIHRresearch | Urology registrar @NorthLonUrol | 🇬🇧🇲🇾🇨🇳
London, England
Joined December 2017
After a great ST3 year with @imperialurology, I'm very excited to start a 3 year @NIHRresearch Doctoral Fellowship with @IP_London! . My PhD will focus on improving the diagnostic and therapeutic strategies for locally recurrent prostate cancer 🚀 . @LondonProstate1 @TaimurShah.
13
6
157
RT @GSCollins: NEW PAPER in @bmj_latest "Dealing with continuous variables and modelling non-linear associations in healthcare data: pract….
0
97
0
RT @Adam_Weiner535: 🚨What's in a name? Why differentiation between biochemical recurrence and metastatic #prostatecancer matters. 👏 New rev….
0
24
0
RT @IP_London: The protocol paper for the #IP7PACIFIC RCT is now available online! This trial led by our group and funded by @CR_UK will pr….
0
10
0
RT @UroResearchNBT: Great news! The IP7-PACIFIC Protocol paper has been published 😍 take a look. 👀 @IP_London @….
0
2
0
RT @ProstateUKProfs: @LondonProstate1 @ShonitP @ProfPadhani @EUplatinum Learn more about the team of researchers leading TRANSFORM, the @Pr….
0
3
0
RT @IP_London: Great to see our PhD student @NikhilMayor present the #TRANSFORM trial at tonight’s @Uroweb UROwebinar: The role of MRI in p….
0
6
0
RT @IP_London: Finishing up #BAUS25 on the main stage our Clinical Lecturer @Connor_Urol presenting an update on two major UK prostate rand….
0
6
0
RT @IP_London: Congratulations to the #IP2ATLANTA trials team on their presentation being selected for best of #BAUS25 . @LondonProstate1 @….
0
5
0
RT @ProstateUKProfs: [4/8] .🦆The TRANSFORM team @NikhilMayor @Fran_Rawlins @AJWLight @philipmcnamee @IP_London @QMULSocialPsych helped supp….
0
4
0
RT @IP_London: Meanwhile! Back at in London, @Fran_Rawlins gave a brilliant presentation showcasing TRANSFORM at the @ImperialCTU Unit Meet….
0
4
0
RT @IP_London: Fantastic overview of diagnostic and therapeutic strategies in radiorecurrent prostate cancer by @TaimurShah . Key takeaways….
0
5
0
RT @BSoT_UK: A superb turnout for our #BAUS25 Fun Run in collaboration with @TUF_tweets . Massive 👏 to our volunteers and especially @SRHur….
0
11
0
RT @IP_London: Brilliant prostate cancer abstract session this morning with 4️⃣ presentations from Team IP at #BAUS25. Huge breadth covered….
0
4
0
RT @IP_London: Wrapping up the session is @Reddy4Urology with the outcomes of 1379 men undergoing #FocalTherapy with #HIFU 🦾 .
0
3
0
RT @IP_London: @NikhilMayor presents outcomes from the first prospective, blinded assessment of #FCM with the #HistologScanner in #RadicalP….
0
3
0
RT @IP_London: Next up @cut_tt_chase presents the 5 year oncological outcomes of men with initial negative #ProstateCancer investigations i….
0
4
0
RT @IP_London: It’s a busy #ProstateCancer session at #BAUS25 - kicking off is @Connor_Urol with the outcomes from the #IP2ATLANTA pilot st….
0
3
0
RT @IP_London: Fantastic to see our FY1 Karen Gao present our data on Rezum for prostates >80mL. Take home - durable results with good pati….
0
4
0
RT @IP_London: Powerful opening from @LondonProstate1 to the #BAUS25 plenary session. We have insufficient capacity and data to endorse scr….
0
7
0
RT @IP_London: #IP2ATLANTA pilot published @EUplatinum . 🔬 9 in 10 patients have a viable prostate tumour despite ADT+ARTA/Doce. 🚦Early sig….
0
11
0